FTX Gene

HGNC Family Non-coding RNAs
Name FTX transcript, XIST regulator (non-protein coding)
Description This gene is located upstream of XIST, within the X-inactivation center (XIC). It produces a spliced long non-coding RNA that is thought to positively regulate the expression of XIST, which is essential for the initiation and spread of X-inactivation. [provided by RefSeq, May 2015]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The long non‐coding RNA FTX, derived from the X chromosome inactivation center, plays multifaceted and context‐dependent roles in both normal physiology and human disease. In several malignancies—including hepatocellular carcinoma, colorectal cancer, pancreatic cancer, glioma, thyroid cancer, and retinoblastoma—FTX is frequently upregulated and acts as an oncogenic driver by functioning as a competing endogenous RNA (ceRNA) that sponges various microRNAs (such as miR‑374a, miR‑545, miR‑215, miR‑320a, miR‑590‑5p, and miR‑513b‑5p), thereby modulating downstream effectors and activating signaling pathways like Wnt/β‑catenin, PI3K/Akt, and glycolytic (PPARγ) cascades."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": " In contrast, in non‐small‐cell lung cancer FTX is downregulated, and forced expression of FTX suppresses cell proliferation and metastasis—an effect partly mediated by upregulating the transcription factor FOXA2 via sequestration of miR‑200a‑3p."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition to its roles in oncogenesis, FTX is an integral component of the X chromosome inactivation network where it participates in a cis‐regulatory cascade (along with JPX and XIST) that is critical for proper dosage compensation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Beyond cancer, FTX has been implicated in protective mechanisms in cardiomyocytes during ischemia/reperfusion injury by modulating the miR‑410‑3p/FMR1 axis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", and in the regulation of osteoclast differentiation through its effects on miR‑137 and Notch1 signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " Finally, meta‐analyses across tumor types reinforce that high FTX expression often correlates with advanced stage and poorer prognosis, underscoring its potential value as a prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " \n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies reveal that FTX exerts diverse functions by modulating post‐transcriptional gene regulation through ceRNA interactions and by contributing to epigenetic control mechanisms—manifesting as either tumor‐promoting or tumor‐suppressive effects depending on the tissue context.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "F Liu, J-H Yuan, J-F Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2016.80"}], "href": "https://doi.org/10.1038/onc.2016.80"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27065331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27065331"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhikui Liu, Changwei Dou, Bowen Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8129"}], "href": "https://doi.org/10.18632/oncotarget.8129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26992218"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26992218"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yi Yang, Jinpei Zhang, Xi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FTX sponges miR-215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene Ther (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41434-018-0026-7"}], "href": "https://doi.org/10.1038/s41434-018-0026-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29925853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29925853"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shan Li, Qian Zhang, Wen Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-021-07975-6"}], "href": "https://doi.org/10.1186/s12885-021-07975-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33736615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33736615"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xiaolei Wang, Yu Su, Chuangao Yin "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1994718"}], "href": "https://doi.org/10.1080/21655979.2021.1994718"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34720057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34720057"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Weiwei Chen, Yuting Li, Liliangzi Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20203995"}], "href": "https://doi.org/10.1042/BSR20203995"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33398336"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33398336"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Shidai Jin, Jing He, Yue Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FTX activates FOXA2 expression to inhibit non-small-cell lung cancer proliferation and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15163"}], "href": "https://doi.org/10.1111/jcmm.15163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32176463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32176463"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Tahsin Stefan Barakat, Friedemann Loos, Selma van Staveren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The trans-activator RNF12 and cis-acting elements effectuate X chromosome inactivation independent of X-pairing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2014.02.006"}], "href": "https://doi.org/10.1016/j.molcel.2014.02.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24613346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24613346"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "L Li, L Li, Y-Z Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FTX alleviates hypoxia/reoxygenation-induced cardiomyocyte injury via miR-410-3p/Fmr1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202001_19938"}], "href": "https://doi.org/10.26355/eurrev_202001_19938"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31957854"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31957854"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yingfeng Yu, Peiquan Yao, Zhikun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of FTX promotes the differentiation of osteoclasts in osteoporosis through the Notch1 signaling pathway by targeting miR-137."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Musculoskelet Disord (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12891-020-03458-0"}], "href": "https://doi.org/10.1186/s12891-020-03458-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32660465"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32660465"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yexiang Lin, Yujie Shen, Jinlan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Function of LncRNA FTX in Several Common Cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1381612826666201029164036"}], "href": "https://doi.org/10.2174/1381612826666201029164036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33121404"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33121404"}]}]}]}
Synonyms LINC00182, NCRNA00182, MIR374AHG
NCBI Gene ID 100302692
API
Download Associations
Predicted Functions View FTX's ARCHS4 Predicted Functions.
Co-expressed Genes View FTX's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View FTX's ARCHS4 Predicted Functions.

Functional Associations

FTX has 1,918 functional associations with biological entities spanning 6 categories (molecular profile, functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 21 datasets.

Click the + buttons to view associations for FTX from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of FTX gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of FTX gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FTX gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of FTX gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of FTX gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FTX gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FTX gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of FTX gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing FTX from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of FTX gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of FTX gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of FTX gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of FTX gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FTX gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of FTX gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of FTX gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of FTX gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by FTX gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of FTX gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FTX gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of FTX gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.